The role of L-3-1-123-iodine-α-methyl tyrosine-SPECT in cerebral gliomas

Summary L-3-1-123-iodine-a-methyltyrosine (IMT) is a 1-123-labelled amino acid which has been used for single photon emission computed tomography (SPECT) of cerebral gliomas for more than a decade. IMT-SPECT is able to detect tumor infiltration independent of disruptions of the blood-brain barrier which is often difficult with computed tomography or magnetic resonance tomography. The method is useful to detect tumor recurrences and helps to distinguish gliomas from non-neoplastic brain masses. IMT-SPECT is thus a valuable tool in the diagnostic evaluation and in therapy planning of patients with cerebral gliomas.

[1]  K. Langen,et al.  Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  M Schwaiger,et al.  First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. , 2000, International journal of radiation oncology, biology, physics.

[3]  O. Schober,et al.  Sequential scintigraphic strategy for the differentiation of brain tumours , 2000, European Journal of Nuclear Medicine.

[4]  M. Weckesser,et al.  Evaluation of the Extension of Cerebral Gliomas by Scintigraphy , 2000, Strahlentherapie und Onkologie.

[5]  J. Moringlane,et al.  Evaluation of l-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy , 1999, European Journal of Nuclear Medicine.

[6]  H. Groen,et al.  Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  K. Zilles,et al.  Comparison of iodotyrosines and methionine uptake in a rat glioma model. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  T. Morioka,et al.  Delayed cerebral radionecrosis with a high uptake of 11C-methionine on positron emission tomography and 201Tl-chloride on single-photon emission computed tomography , 1998, Neuroradiology.

[9]  O. Schober,et al.  Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  D. Kinzel,et al.  Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  S. Goldman,et al.  Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. , 1996, Neurosurgery.

[13]  E. Ryding,et al.  Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. , 1996, AJNR. American journal of neuroradiology.

[14]  I. Kanno,et al.  Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  A. Jacobs,et al.  Amino acid uptake in ischemically compromised brain tissue. , 1995, Stroke.

[16]  K. Sartor,et al.  Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. , 1995, Neurosurgery.

[17]  R. Iwata,et al.  Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  A. Luxen,et al.  Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  E. Jackson,et al.  Current imaging techniques for the evaluation of brain neoplasms. , 1994, Current opinion in oncology.

[20]  K Herholz,et al.  Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. , 1993, Journal of neurosurgery.

[21]  M. Senda,et al.  Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Iwao Kanno,et al.  High L‐Methyl‐[11C]Methionine Uptake in Brain Abscess: A PET Study , 1993, Journal of computer assisted tomography.

[23]  K Wienhard,et al.  Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  Y. Yonekura,et al.  A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  M. Bergström,et al.  Delineation of Gliomas with Magnetic Resonance Imaging Using Gd-DTPA in Comparison with Computed Tomography and Positron Emission Tomography , 1990, Acta radiologica.

[26]  H. Herzog,et al.  SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  A. Syrota,et al.  [11C]L-methionine uptake in gliomas. , 1989, Neurosurgery.

[28]  M. Bergström,et al.  Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas Using Multiple Stereotactic Biopsies as Reference , 1989, Acta radiologica.

[29]  M. Bergström,et al.  Positron Emission Tomography with 11C-Methionine and Computed Tomography of Intracranial Tumours Compared with Histopathologic Examination of Multiple Biopsies , 1987, Acta radiologica.

[30]  O. Schober,et al.  Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells. , 1999, European journal of nuclear medicine.

[31]  O. Schober,et al.  Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  Susan M. Chang,et al.  18‐fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma , 1997, Cancer.

[33]  H. Herzog,et al.  Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine. , 1997, European journal of nuclear medicine.

[34]  O. Schober,et al.  Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. , 1996, European journal of nuclear medicine.

[35]  N. Rollins,et al.  Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. , 1995, Pediatric neurosurgery.

[36]  K. Dutschka,et al.  Anreicherung von DL-3-123I-Jod-α-Methyltyrosin in Hirntumorrezidiven , 1995, Nuklearmedizin.

[37]  A. Bockisch,et al.  Imaging of Brain Tumors with L-3-[123I]Iodo-α-Methyl Tyrosine and SPECT , 1989 .

[38]  Brain and Brain Tumor Uptake of L-3-['231]Iodo a.-MethylTyrosine: Competition with Natural L-Amino Acids , 2022 .